CNBS : Amplify Seymour Cannabis ETF

CNBS is a Allocation Market Other with HIGH fees.

CNBS

Amplify Seymour Cannabis ETF

FI Score

8 /100

Diversification Rating

0 /10

Expense Ratio Rating

1 /10

Expense Rating

3 /10

Market Score

0 /10

Category Score

0 /10

Market Size

0 /10

  • cnbs
  • ETF
  • Allocation
  • Other

Amplify Seymour Cannabis ETF

Expenses: 0.75% (Better than 0% of similar funds)

This is a bad choice for a Other Allocation fund. See why ยป

Fund Summary

The investment seeks to provide investors capital appreciation. The fund will invest at least 80% of its net assets (including investment borrowings) in the securities of companies that derive 50% or more of their revenue from the cannabis and hemp ecosystem. It is an actively managed ETF that seeks to provide investment exposure to global companies principally engaged in the emerging cannabis and hemp ecosystem across one of three classifications. The fund is non-diversified.

Largest Holdings

Amount Holding
12.01% Canopy Growth Corporation
11.44% GW Pharmaceuticals PLC ADR
9.24% Cronos Group Inc
6.80% Innovative Industrial Properties, Inc
6.62% PerkinElmer, Inc
6.31% Aphria Inc
5.12% GrowGeneration Corp
4.49% Arena Pharmaceuticals, Inc
4.06% Silver Spike Acquisition Corp
3.72% Neptune Wellness Solutions Inc

Minafi - The intersection of FI, minimalism & mindfulness.

Don't miss out on new posts, courses, interactive articles and more!

Join & Get Your First Course Free

© 2024   Adam Fortuna

Site Map
Triangle Graduation Cap Angle Down Book regular Phone laptop regular fire regular fire regular search regular Acorn duotone Seedling duotone thumbs down duo